Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SPATA4 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA532139
Description
Recommended positive controls: NT2D1, PC-3, U87-MG, mouse testis. Predicted reactivity: Rhesus Monkey (90%), Chimpanzee (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The testis spermatocyte apoptosis-related gene 2 protein (TSARG2, also designated spermatogenesis associated-4 or SPATA4) is involved in spermatogenesis. TSARG2 is specifically expressed in spermatogonia and spermatocytes of the seminiferous tubules, and it localizes to the nucleus. The predicted molecular weight of TSARG2 ranges depending on the species. TSARG2 is significantly upregulated in cryptorchidism and therefore, is a testis-specific apoptosis candidate oncogene.
Specifications
SPATA4 | |
Polyclonal | |
Unconjugated | |
SPATA4 | |
1700001N01Rik; Spata4; SPEF1B; spermatogenesis associated 4; spermatogenesis related gene 2; spermatogenesis-associated 4; spermatogenesis-associated protein 4; Spermatogenesis-related gene 2 protein; Srg2; testis and spermatogenesis cell related protein 2; testis and spermatogenesis cell-related protein 2; Testis spermatocyte apoptosis-related gene 2 protein; TSARG2 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
132851, 69281 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q8K3V1, Q8NEY3 | |
SPATA4 | |
Recombinant fragment corresponding to a region within amino acids 86 and 305 of Human TSARG2. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction